Pharmacists' acceptable levels of compensation for MTM services

A conjoint analysis

Junling Wang, Song Hee Hong, Songmei Meng, Lawrence M. Brown

Research output: Contribution to journalArticle

9 Citations (Scopus)

Abstract

Background: The Medicare Modernization Act of 2003 requires prescription drug plans to provide medication therapy management (MTM) services to Medicare beneficiaries who are at high risk for inappropriate use of medications. However, inadequate compensation has been a barrier for MTM expansion among pharmacists. Objectives: The objective of this study was to determine pharmacists' acceptable levels of compensation for MTM services. Methods: A preference-based fractional factorial design of conjoint analysis was used by surveying 1524 active pharmacists in Tennessee. Pharmacists were asked to select between packages (scenarios) of MTM services that represented combinations of MTM attributes (characteristics). The MTM attributes included type of patient (new or returning), patient's number of chronic conditions (1, 3, or 6), patient's number of medications (4, 8, or 16), patient's annual drug costs ($2000, $3000, or $4000), service duration (15 minutes, 30 minutes, or 45 minutes), and price of MTM services ($30, $60, or $120). A survival analysis model was used to predict pharmacists' willingness to select 1 versus another MTM service package. Pharmacists' acceptable level of compensation was estimated as the marginal rate of substitution between the parameter estimates of an attribute and the price attribute of MTM. Results: The parameter estimates were -0.0303 (P< .0001) for service duration and 0.0210 (P< .0001) for price of MTM services, respectively, so pharmacists were willing to accept $1.44/min (0.0303/0.0210), or $86.4/h, for MTM services. Pharmacists' characteristics were associated significantly with their acceptable levels of compensation: years of practice was associated with a higher need for compensation, pharmacy ownership (vs nonowner) associated with a lower need, and having provided MTM previously (vs having not provided MTM) was associated with a higher need. Conclusions: Pharmacists' acceptable level of compensation is in the higher part of current ranges from $30 to $100/h. To increase participation in MTM services, pharmacist compensation needs to be increased. Future studies might continue to corroborate the generalizability of findings from this study.

Original languageEnglish (US)
Pages (from-to)383-395
Number of pages13
JournalResearch in Social and Administrative Pharmacy
Volume7
Issue number4
DOIs
StatePublished - Dec 1 2011

Fingerprint

Medication Therapy Management
Pharmacists
Medicare
Compensation and Redress
Drug Costs
Prescription Drugs
Ownership
Surveying
Modernization
Survival Analysis

All Science Journal Classification (ASJC) codes

  • Pharmacy
  • Pharmaceutical Science

Cite this

Pharmacists' acceptable levels of compensation for MTM services : A conjoint analysis. / Wang, Junling; Hong, Song Hee; Meng, Songmei; Brown, Lawrence M.

In: Research in Social and Administrative Pharmacy, Vol. 7, No. 4, 01.12.2011, p. 383-395.

Research output: Contribution to journalArticle

Wang, Junling ; Hong, Song Hee ; Meng, Songmei ; Brown, Lawrence M. / Pharmacists' acceptable levels of compensation for MTM services : A conjoint analysis. In: Research in Social and Administrative Pharmacy. 2011 ; Vol. 7, No. 4. pp. 383-395.
@article{e105adcee4774747bd3e0fb2da4ca6c0,
title = "Pharmacists' acceptable levels of compensation for MTM services: A conjoint analysis",
abstract = "Background: The Medicare Modernization Act of 2003 requires prescription drug plans to provide medication therapy management (MTM) services to Medicare beneficiaries who are at high risk for inappropriate use of medications. However, inadequate compensation has been a barrier for MTM expansion among pharmacists. Objectives: The objective of this study was to determine pharmacists' acceptable levels of compensation for MTM services. Methods: A preference-based fractional factorial design of conjoint analysis was used by surveying 1524 active pharmacists in Tennessee. Pharmacists were asked to select between packages (scenarios) of MTM services that represented combinations of MTM attributes (characteristics). The MTM attributes included type of patient (new or returning), patient's number of chronic conditions (1, 3, or 6), patient's number of medications (4, 8, or 16), patient's annual drug costs ($2000, $3000, or $4000), service duration (15 minutes, 30 minutes, or 45 minutes), and price of MTM services ($30, $60, or $120). A survival analysis model was used to predict pharmacists' willingness to select 1 versus another MTM service package. Pharmacists' acceptable level of compensation was estimated as the marginal rate of substitution between the parameter estimates of an attribute and the price attribute of MTM. Results: The parameter estimates were -0.0303 (P< .0001) for service duration and 0.0210 (P< .0001) for price of MTM services, respectively, so pharmacists were willing to accept $1.44/min (0.0303/0.0210), or $86.4/h, for MTM services. Pharmacists' characteristics were associated significantly with their acceptable levels of compensation: years of practice was associated with a higher need for compensation, pharmacy ownership (vs nonowner) associated with a lower need, and having provided MTM previously (vs having not provided MTM) was associated with a higher need. Conclusions: Pharmacists' acceptable level of compensation is in the higher part of current ranges from $30 to $100/h. To increase participation in MTM services, pharmacist compensation needs to be increased. Future studies might continue to corroborate the generalizability of findings from this study.",
author = "Junling Wang and Hong, {Song Hee} and Songmei Meng and Brown, {Lawrence M.}",
year = "2011",
month = "12",
day = "1",
doi = "10.1016/j.sapharm.2010.09.003",
language = "English (US)",
volume = "7",
pages = "383--395",
journal = "Research in Social and Administrative Pharmacy",
issn = "1551-7411",
publisher = "Elsevier Inc.",
number = "4",

}

TY - JOUR

T1 - Pharmacists' acceptable levels of compensation for MTM services

T2 - A conjoint analysis

AU - Wang, Junling

AU - Hong, Song Hee

AU - Meng, Songmei

AU - Brown, Lawrence M.

PY - 2011/12/1

Y1 - 2011/12/1

N2 - Background: The Medicare Modernization Act of 2003 requires prescription drug plans to provide medication therapy management (MTM) services to Medicare beneficiaries who are at high risk for inappropriate use of medications. However, inadequate compensation has been a barrier for MTM expansion among pharmacists. Objectives: The objective of this study was to determine pharmacists' acceptable levels of compensation for MTM services. Methods: A preference-based fractional factorial design of conjoint analysis was used by surveying 1524 active pharmacists in Tennessee. Pharmacists were asked to select between packages (scenarios) of MTM services that represented combinations of MTM attributes (characteristics). The MTM attributes included type of patient (new or returning), patient's number of chronic conditions (1, 3, or 6), patient's number of medications (4, 8, or 16), patient's annual drug costs ($2000, $3000, or $4000), service duration (15 minutes, 30 minutes, or 45 minutes), and price of MTM services ($30, $60, or $120). A survival analysis model was used to predict pharmacists' willingness to select 1 versus another MTM service package. Pharmacists' acceptable level of compensation was estimated as the marginal rate of substitution between the parameter estimates of an attribute and the price attribute of MTM. Results: The parameter estimates were -0.0303 (P< .0001) for service duration and 0.0210 (P< .0001) for price of MTM services, respectively, so pharmacists were willing to accept $1.44/min (0.0303/0.0210), or $86.4/h, for MTM services. Pharmacists' characteristics were associated significantly with their acceptable levels of compensation: years of practice was associated with a higher need for compensation, pharmacy ownership (vs nonowner) associated with a lower need, and having provided MTM previously (vs having not provided MTM) was associated with a higher need. Conclusions: Pharmacists' acceptable level of compensation is in the higher part of current ranges from $30 to $100/h. To increase participation in MTM services, pharmacist compensation needs to be increased. Future studies might continue to corroborate the generalizability of findings from this study.

AB - Background: The Medicare Modernization Act of 2003 requires prescription drug plans to provide medication therapy management (MTM) services to Medicare beneficiaries who are at high risk for inappropriate use of medications. However, inadequate compensation has been a barrier for MTM expansion among pharmacists. Objectives: The objective of this study was to determine pharmacists' acceptable levels of compensation for MTM services. Methods: A preference-based fractional factorial design of conjoint analysis was used by surveying 1524 active pharmacists in Tennessee. Pharmacists were asked to select between packages (scenarios) of MTM services that represented combinations of MTM attributes (characteristics). The MTM attributes included type of patient (new or returning), patient's number of chronic conditions (1, 3, or 6), patient's number of medications (4, 8, or 16), patient's annual drug costs ($2000, $3000, or $4000), service duration (15 minutes, 30 minutes, or 45 minutes), and price of MTM services ($30, $60, or $120). A survival analysis model was used to predict pharmacists' willingness to select 1 versus another MTM service package. Pharmacists' acceptable level of compensation was estimated as the marginal rate of substitution between the parameter estimates of an attribute and the price attribute of MTM. Results: The parameter estimates were -0.0303 (P< .0001) for service duration and 0.0210 (P< .0001) for price of MTM services, respectively, so pharmacists were willing to accept $1.44/min (0.0303/0.0210), or $86.4/h, for MTM services. Pharmacists' characteristics were associated significantly with their acceptable levels of compensation: years of practice was associated with a higher need for compensation, pharmacy ownership (vs nonowner) associated with a lower need, and having provided MTM previously (vs having not provided MTM) was associated with a higher need. Conclusions: Pharmacists' acceptable level of compensation is in the higher part of current ranges from $30 to $100/h. To increase participation in MTM services, pharmacist compensation needs to be increased. Future studies might continue to corroborate the generalizability of findings from this study.

UR - http://www.scopus.com/inward/record.url?scp=82455212469&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=82455212469&partnerID=8YFLogxK

U2 - 10.1016/j.sapharm.2010.09.003

DO - 10.1016/j.sapharm.2010.09.003

M3 - Article

VL - 7

SP - 383

EP - 395

JO - Research in Social and Administrative Pharmacy

JF - Research in Social and Administrative Pharmacy

SN - 1551-7411

IS - 4

ER -